astemizole has been researched along with Maculopapular Cutaneous Mastocytosis in 1 studies
Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Astemizole 10 mg tds was given for 6 weeks to achieve complete H1 receptor blockade and the response measured by change in force-weal response measurements using two different forces on a dermographic stylus and measuring response as weal diameter." | 1.27 | Minimal effect of complete H1 receptor blockade on urticaria pigmentosa. ( Krause, LB; Shuster, S, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krause, LB | 1 |
| Shuster, S | 1 |
1 other study available for astemizole and Maculopapular Cutaneous Mastocytosis
| Article | Year |
|---|---|
Minimal effect of complete H1 receptor blockade on urticaria pigmentosa.
Topics: Adult; Astemizole; Benzimidazoles; Female; Histamine H1 Antagonists; Histamine Release; Humans; Male | 1985 |